This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Apo-Mycophenolic Acid (2014-08-15)
- Starting date:
- August 15, 2014
- Posting date:
- September 2, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-41269
Recalled Products
Apo-Mycophenolic Acid
Reason
Apo-Mycophenolic Acid Tablets Carton for the 360 mg strength 120s Blister has the incorrect tablet strength on the French panel. It states that the tablet has 180 mg of active rather than the correct strength of 360 mg. All remaining information for the product including the rest of the carton, the leaflets, and the blister labels are correct.
Depth of distribution
Retail / Nationwide: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec and Saskatchewan.
Affected products
Apo-Mycophenolic Acid
DIN, NPN, DIN-HIM
DIN 02372746
Dosage form
Tablets
Strength
360 mg
Lot or serial number
KY6601
Companies
- Recalling Firm
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
- Marketing Authorization Holder
-
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA